Cardiology Practice Management Complete Guide 2026

A cardiologist finishing Tuesday clinic has fourteen ECGs waiting to be read, six warfarin patients whose INR results landed overnight, a pacemaker interrogation that flagged a lead-impedance drift, and a front desk asking why an eligibility response never came back for tomorrow's new consult. Running a cardiology practice well means closing the distance between all of that -- the read, the dose, the device trend, the claim -- without four systems that refuse to talk to each other. Deelo does it by pairing AI-assisted ECG interpretation with the whole practice's operations on one platform, and a licensed cardiologist still reviews and owns every final read.

This guide is about operations, not algorithms. It walks the workflows a working cardiology practice runs every week and shows where each one lives in Deelo: the ECG interpretation loop from upload to sign-off, an anticoagulation clinic that doses by protocol, ASCVD risk-reduction programs that recall patients on schedule, cardiac device interrogation trending, plus the unglamorous spine of scheduling, records, eligibility, and claims that keeps the lights on. It is also honest about the ceiling. Deelo is not a deep enterprise cardiology EHR wired into your cath lab and nuclear cameras, and if that integration is the center of your practice, you will pair Deelo with those systems rather than replace them.

Strip away the buzzwords and a cardiology practice is a set of recurring loops, each with its own clock. ECGs need reading the same day. Warfarin patients need an INR result classified and a dose returned before they leave the parking lot. A patient on a statin program needs a recall in six months, not whenever someone remembers. A pacemaker check needs its lead parameters trended against the last visit so drift shows up early. And under all of it, eligibility has to be verified before the visit and the claim has to go out clean afterward, or the revenue quietly leaks.

Most practices run each loop in a different tool. The ECG read sits in one system, the anticoagulation log in a spreadsheet, the recall list in someone's head, and the billing in a service that charges per claim. The cost is not any single tool. It is the handoffs between them, where a critical INR gets missed on a busy afternoon or a claim sits unsent for a week.

The center of a cardiology practice is still the ECG, and the workflow Deelo's Cardiology app runs is deliberately a loop with a human at the end of it. A tracing comes in and the AI produces a first-pass read: rhythm detection that separates normal sinus from atrial fibrillation, flutter, and conduction blocks; interval analysis that measures PR, QRS, and QT/QTc and flags the abnormal ones; and ST-T wave analysis that surfaces ST elevation or depression and T-wave changes for ischemia screening. On top of that sits AI risk stratification, which ranks the tracing and attaches urgent-action recommendations so a possible STEMI does not wait in a queue behind routine follow-ups.

That is the assist. The read is not final until a licensed cardiologist reviews it and signs off, and that ownership is the point, not a footnote. The AI is decision support that speeds triage and catches the arrhythmia hiding in a stack of normals; the physician remains responsible for the interpretation that goes in the chart. Everything in the loop -- ECG notes, the interpretation, and patient identifiers -- is field-encrypted at rest on Deelo's HIPAA-supporting infrastructure, with a signed BAA available and per-role access so a technician uploading tracings does not see what a biller does. The practical win is speed with a safety net: the tracing that needs attention now rises to the top, and the routine ones move faster.

Warfarin management is where small practices bleed time and risk, because it is high-frequency, protocol-driven, and unforgiving of a missed value. Deelo's Cardiology app runs it as a proper anticoagulation clinic rather than a logbook. An INR result comes in and gets classified against the patient's target range -- subtherapeutic, in range, or supratherapeutic -- and the app suggests a dose adjustment by protocol so the response is consistent whether the patient is seen by the cardiologist or a nurse working to a standing order. Over time it computes time-in-therapeutic-range, the number that actually predicts whether a patient is safe, so you can see who is stable and who needs a tighter recheck interval.

The part that matters most on a busy day is the critical-INR alert. A dangerously high value does not sit politely in a worklist; it is flagged for immediate action so a bleed risk gets a phone call, not a next-day callback. Run across a whole panel of anticoagulation patients, this turns a scattered spreadsheet-and-memory process into a clinic you can actually audit: every result classified, every adjustment tied to a protocol, and time-in-therapeutic-range trended per patient. The clinical judgment stays with the clinician; the app removes the clerical gaps where a critical value slips through.

Prevention only works if it is longitudinal, and that is exactly where paper programs fall apart. Deelo's Cardiology app calculates 10-year ASCVD risk using the Pooled Cohort Equations and, more usefully, keeps a longitudinal risk timeline so you can see whether a patient's risk is bending down as a statin and lifestyle changes take hold, or creeping up despite them. A single score is a snapshot; a timeline is a program.

The operational half is recall, and the rest of Deelo carries that load. A statin patient who should be re-evaluated in six months goes into Deelo's CRM as part of a recall pipeline, and the Marketing app sends the reminder and rebooking prompt on schedule instead of relying on someone to notice. The same machinery handles the annual lipid recheck and the lifestyle-counseling follow-up. Tie the clinical timeline to an automated recall list and a risk-reduction program stops being a good intention that decays after the first visit. It becomes a repeatable loop: score, intervene, recall, re-score. None of this replaces the clinician's decision on who to treat and how. It makes sure the patients who need the next touch actually get booked for it.

Pacemaker and ICD follow-up is a trending problem, not a snapshot problem, and a single interrogation printout tells you almost nothing without the last one next to it. Deelo's Cardiology app records device interrogations and trends them over time, capturing the per-lead electrical parameters so a slow rise in lead impedance or a drift in capture threshold shows up as a line moving the wrong way rather than a number someone has to remember. That is the difference between catching a lead problem at a routine check and finding out about it when the device stops doing its job.

Because the interrogation history lives in the same patient record as the ECGs, anticoagulation results, and ASCVD timeline, a device patient's whole cardiac picture sits in one place. The clinician still reads the interrogation and decides what it means. The app's job is to keep the series intact and make the trend legible, so device follow-up is a scheduled, comparable check instead of a stack of loose reports that only get compared after something has already gone wrong.

The clinical apps sit on top of the operational workhorse, which for a cardiology practice is Deelo's Practice Management app. Scheduling handles provider availability, room assignments, and a waitlist, so a cancellation gets backfilled instead of becoming an empty chair. Patient records hold demographics, insurance, and medical history in one place, under the same HIPAA encryption and per-role PHI access that governs the clinical data. E-prescribing runs through RxNorm search with interaction and allergy checks and an EPCS gate for controlled substances, and clinical decision support flags drug-drug interactions at the point of ordering with an audited override when the clinician chooses to proceed.

The revenue cycle is where consolidation pays for itself. Practice Management runs real-time 270/271 eligibility checks before the visit, so you know coverage before the patient sits down. After the encounter it submits 837P professional claims, then auto-posts 835 ERA remittances with adjustment handling, so payments and write-offs land against the right claim without someone keying them by hand. Deelo's Invoicing app covers patient-responsibility balances, superbills, and statements. The pieces that usually live in three separate vendors -- eligibility, claims, and remittance -- run as one connected pipeline instead of a relay race with dropped batons.

There are three honest ways to buy technology for a cardiology practice, and they solve different problems. A standalone AI ECG vendor goes deep on the read and nothing else. An enterprise cardiology EHR covers everything and configures and prices like it. Deelo sits in between: an AI-assisted read plus the practice's operations and billing on one subscription. The table below is about focus, not scorekeeping. Pick the row that matches where your practice actually spends its effort.

Read the last column against the first. A standalone AI ECG tool can produce a superb read, but it hands the rest of your week back to you and the systems you already run. An enterprise cardiology EHR will cover the anticoagulation clinic, the device trending, and the imaging integrations in real depth, and for a large group with a cath lab and nuclear cameras that depth is the reason to buy it, along with the implementation timeline and cost that come with it. Deelo's advantage is the column no single-lane tool owns: it puts the AI-assisted ECG read, the warfarin clinic, the ASCVD timeline, device trending, scheduling, eligibility, claims, and recall on one login, from about $19 per seat per month on one subscription. Competitor pricing across the specialty EHRs varies widely by module and group size (2026 -- verify current pricing). The question is not which tool is best in the abstract. It is which column your practice is losing time in, and whether you would rather consolidate or buy specialty depth.

Deelo is a consolidation play with AI-assisted reads, and there is a clear line where that stops being the right answer. It is not a full enterprise cardiology EHR. If your practice runs a cath lab, an echo suite, nuclear cardiology, or advanced imaging that has to integrate tightly with structured reporting and modality worklists, Deelo does not replace those systems, and you should pair it with them rather than expect it to absorb them. Deep, specialty-specific charting workflows that a dedicated cardiology EHR has spent years refining are not Deelo's claim either.

The other line worth stating plainly: the AI ECG read is assistive. It is decision support that triages and flags, and a licensed cardiologist reviews every tracing and owns the interpretation that reaches the chart. Deelo does not autonomously diagnose, it is not FDA cleared, and no vendor should tell you their algorithm removes the physician from the loop. Buy Deelo to consolidate operations and speed triage, not to outsource the read.